GlobeNewswire by notified

Solidium’s CEO to change

Share

Solidium’s CEO, Antti Mäkinen, will leave his position as the CEO of Solidium on 31st May 2022. Mäkinen, 60, has acted as CEO of the company since year 2017.

“The past five years have been rewarding and I have had the opportunity to work with an excellent team and great portfolio companies. Solidium has an established position and a strong track in growing shareholder value”, says Mäkinen.

Antti Mäkinen has acted as a Board Member and Chairman of the Shareholders’ Nomination Committee in many of Solidium’s portfolio companies. He is still nominated this Spring in the Annual General Meetings i.a. as the Chairman of the Board in Stora Enso and a Member of the Board in Metso Outotec.

The Chairman of the Board of Solidium, Harri Sailas, would like to thank Mäkinen for his work both in charge of Solidium and as Solidium’s representative in the portfolio companies.

“In Antti Mäkinen’s steering, Solidiums position has stabilized and the company has been more active both as an owner and in making new investments. His performance has been appreciated among all company stakeholders”, says Harri Sailas.

Solidium starts the search of new CEO immediately.


Further information: Antti Mäkinen, CEO and Harri Sailas, Chairman of the Board; call-back requests, Jaana Lahti, tel. +358 50 339 8801


Solidium is a limited liability company wholly owned by the State of Finland. Its mission is to strengthen and stabilise Finnish ownership in nationally important companies and increase the value of its holdings in the long term. Through its stakes, Solidium is a minority owner in twelve listed companies: Anora, Elisa, Kemira, Konecranes, Metso Outotec, Nokia, Nokian Tyres, Outokumpu, Sampo, Stora Enso, TietoEVRY and Valmet. The market value of Solidium’s total investments is approximately 9,4 billion euros. Further information: www.solidium.fi.

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Danske Bank A/S, ledende medarbejderes transaktioner19.3.2024 12:08:46 CET | pressemeddelelse

19. marts 2024 Indberetning nr. 24/2024 Ændring i aktiebesiddelser hos Danske Banks indberetningspligtige i henhold til EU-forordningen om markedsmisbrug I forbindelse med Danske Bank A/S’ aktietilbagekøbsprogram sælger APMH Invest A/S løbende aktier i Danske Bank A/S pro rata. For yderligere detaljer henvises til de vedhæftede skemaer, hvori transaktioner udført af personer med ledelsesansvar og personer med nær tilknytning til disse skal indberettes og offentliggøres. Kontakt: Stefan Singh Kailay, Head of Media Relations, tel. +45 45 14 14 00 Vedhæftet fil APMH Invest A_S - salg - 2024-03-18

Danske Bank A/S, transactions by persons discharging managerial responsibilities19.3.2024 12:08:46 CET | Press release

19 March 2024 Notification no. 24/2024 Transactions made by persons obliged to report transactions to the Danish FSA and Nasdaq Copenhagen, cf. the EU Market Abuse Regulation. In connection with the share buy-back program in Danske Bank A/S, APMH Invest A/S continuously sells shares pro rata. For further details, please find the attached templates for notifications and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them. Contact: Stefan Singh Kailay, Head of Media Relations, tel. +45 45 14 14 00 Attachment APMH Invest AS - sale - 2024-03-18

SPEVIGO® approved for expanded indications in China and the US19.3.2024 12:00:00 CET | Press release

Generalized pustular psoriasis (GPP) is a rare, chronic, heterogenous neutrophilic inflammatory disease associated with skin and systemic symptoms, such as fever, pain, and fatigue1,2,3,4In China, SPEVIGO®’s expanded approval adds the reduction of occurrences of GPP in pediatric patients aged 12 and above weighing ≥40 kg, and adults5The US FDA’s approval expands the use of SPEVIGO® to include the treatment of GPP in adults and pediatric patients aged 12 and above weighing ≥40 kg, making it the first targeted therapy that addresses the need for acute and chronic treatment for GPP patients6SPEVIGO® is currently approved in 48 countries7 Boehringer Ingelheim today announced that the US Food and Drug Administration (FDA) has approved SPEVIGO® (spesolimab-sbzo) injection for the treatment of generalized pustular psoriasis (GPP) in adults and pediatric patients aged 12 and above weighing ≥40 kg.5 This approval follows the Chinese National Medical Products Administration’s (NMPA) recent appro

Equinor ASA: Kjøp av aksjer til aksjeprogram for ansatte19.3.2024 11:57:54 CET | Pressemelding

Nedenfor følger informasjon om transaksjoner knyttet til tilbakekjøpsprogrammet for Equinor ASA (OSE:EQNR, NYSE:EQNR) til bruk i aksjebaserte insentivprogrammer for ansatte og ledelse. Dato for annonsering av tilbakekjøpsprogrammet: 7. februar 2024. Varighet av tilbakekjøpsprogrammet: 15. februar 2024 til 15. januar 2025. Størrelse av tilbakekjøpsprogrammet: Samlet kjøpesum i tilbakekjøpsprogrammet er inntil NOK 1.156.000.000 og det maksimale antall aksjer som kan erverves er 16.800.000, hvorav opp til 7.400.000 aksjer kan erverves i perioden fra 15. februar 2024 til 15. mai 2024, og opptil 9.400.000 aksjer kan erverves i perioden fra 16. juni 2024 til 15. januar 2025. Den 15. mars 2024 kjøpte Equinor ASA totalt 482.159 egne aksjer ved Oslo Børs til en gjennomsnittspris på NOK 279,9906 pr. aksje. Oversikt over transaksjoner: DateAggregert volum (antall aksjer)Vektet gjennomsnittspris pr. aksje (NOK) Total transaksjonsverdi (NOK) 15 mars 2024482.159279,9906134.999.988Totalt tidligere of

Equinor ASA: Buy-back of shares to share programmes for employees19.3.2024 11:57:54 CET | Press release

Please see below information about transactions made under the buy-back programme for Equinor ASA (OSE:EQNR, NYSE:EQNR) for shares to be used in the share-based incentive programmes for employees and management. Date on which the buy-back programme was announced: 7 February 2024. The duration of the buy-back programme: 15 February 2024 to 15 January 2025. Size of the buy-back programme: The total purchase amount under the programme is NOK 1,156,000,000 and the maximum shares to be acquired is 16,800,000 shares, of which up to 7,400,000 shares can be acquired in the period from 15 February 2024 to 15 May 2024, and up to 9,400,000 shares can be acquired in the period from 16 May 2024 to 15 January 2025. On 15 March 2024, Equinor ASA has purchased a total of 482,159 own shares at the Oslo Stock Exchange at an average price of NOK 279.9906 per share. Aggregated overview of transactions per day: DateAggregated volume (number of shares)Weighted average share price (NOK) Total transaction val

HiddenA line styled icon from Orion Icon Library.Eye